Unique ID issued by UMIN | UMIN000028153 |
---|---|
Receipt number | R000032222 |
Scientific Title | Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital |
Date of disclosure of the study information | 2017/08/15 |
Last modified on | 2020/01/20 17:12:38 |
Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital
Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital
Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital
Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital
Japan |
type2 diabetes
Endocrinology and Metabolism |
Others
NO
To explore the effect on glycemic control and the risk of dibetic complications in patients with type 2 diabetes treated with dapagliflozin.
Efficacy
Exploratory
Pragmatic
Not applicable
HbA1c, glycoalbumin
Body weight, Abdominal circumference, blood pressure, liver function, renal function, uric acid, lipid parameters
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Addition of dapagliflozin 5mg
20 | years-old | <= |
75 | years-old | > |
Male and Female
1) Outpatients
2) over 20 years old
3) T2DM
4) eGFR over 30 mL/min/1.73 m2
5) Diet and exercise therapies are well performed
6) Patients who are suspected good-compliant
7) Understanding of the study procedures and agreement to participate in the study, by giving written informed consent
1) Patients suspected of having secondary diabetes (ex. endocrine disease, drug-induced or liver disease)
2) Females who are pregnant or who intend to become pregnant within the study
3) Severe hepatic disease, malignancy, a history of gastrectomy and/or positive for HIV
4) Contraindication with dapagliflozin
5) Patient who disqualified from the study by the investigator for any reason other than given above.
42
1st name | Yasuhiro |
Middle name | |
Last name | Iijima |
Tokyo Medical University
Department of Diabetes, Endocrinology and Metabolism
160-0023
6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo
03-3342-6111
yasuhiro.iijima1203@gmail.com
1st name | Yasuhiro |
Middle name | |
Last name | Iijima |
Manda Memorial Hospital
Diabetes Center
060-0062
Minami 2, Nishi 1, Chuo-ku, Sapporo
011-231-4032
yasuhiro.iijima1203@gmail.com
Tokyo Medical University
none
Self funding
Todachuo General Hospital
1-19-3 Honcho, Toda City, Saitama Prefecture
048-442-1111
yasuhiro.iijima1203@gmail.com
NO
戸田中央総合病院
2017 | Year | 08 | Month | 15 | Day |
Unpublished
No longer recruiting
2014 | Year | 08 | Month | 19 | Day |
2014 | Year | 06 | Month | 25 | Day |
2014 | Year | 08 | Month | 19 | Day |
2017 | Year | 12 | Month | 31 | Day |
2017 | Year | 07 | Month | 10 | Day |
2020 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032222
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |